Therefore, we measured serum leptin, adiponectin, and IGF-1 in two independent cohorts, comprising both biopsy-proven healthy-liver controls as well as obese NAFL and NASH patients. This evidence concerns the gene ADIPOQ and metabolic dysfunction-associated steatohepatitis.